High frequency of cytolytic 21-hydroxylase-specific CD8+T cells in autoimmune Addison's disease patients

Journal of Immunology

Volumn 193, Issue 5, 2014, Pages 2118-2126

  Dawoodji, Amina ^a   Chen, Ji Li ^a   Shepherd, Dawn ^a   Dalin, Frida ^b   Tarlton, Andrea ^a   Alimohammadi, Mohammad ^b   Penna Martinez, Marissa ^c   Meyer, Gesine ^c   Mitchell, Anna L ^d   Gan, Earn H ^d   Bratland, Eirik ^e,f   Bensing, Sophie ^a,b   Husebye, Eystein S ^e,f   Pearce, Simon H ^d   Badenhoop, Klaus ^c   Kämpe, Olle ^b,g   Cerundolo, Vincenzo ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF BERGEN   (Norway)

^f HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^g UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; STEROID 21 MONOOXYGENASE; PEPTIDE;

ADDISON DISEASE; ADOLESCENT; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; ENZYME SPECIFICITY; ENZYME STRUCTURE; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IN VITRO STUDY; MALE; MIDDLE AGED; TARGET CELL; YOUNG ADULT; ADRENAL CORTEX TUMOR; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL TRIAL; IMMUNOLOGY; MULTICENTER STUDY; PATHOLOGY;

ADDISON DISEASE; ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; HUMANS; IMMUNITY, CELLULAR; MIDDLE AGED; PEPTIDES; STEROID 21-HYDROXYLASE;

EID: 84907020081     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400056     Document Type: Article

References (26)

1. Arlt, W., and B. Allolio. 2003. Adrenal insufficiency. Lancet 361: 1881-1893.
2. Betterle, C., and R. Zanchetta. 2003. Update on autoimmune polyendocrine syndromes (APS). Acta Biomed. 74: 9-33.
3. Husebye, E. S., B. Allolio, W. Arlt, K. Badenhoop, S. Bensing, C. Betterle, A. Falorni, E. H. Gan, A. L. Hulting, A. Kasperlik-Zaluska, et al. 2014. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J. Intern. Med. 275: 104-115.
4. Winqvist, O., F. A. Karlsson, and O. Kämpe. 1992. 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet 339: 1559-1562.
5. Erichsen, M. M., K. Løvås, B. Skinningsrud, A. B. Wolff, D. E. Undlien, J. Svartberg, K. J. Fougner, T. J. Berg, J. Bollerslev, B. Mella, et al. 2009. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J. Clin. Endocrinol. Metab. 94: 4882-4890.
6. Coco, G., C. Dal Pra, F. Presotto, M. P. Albergoni, C. Canova, B. Pedini, R. Zanchetta, S. Chen, J. Furmaniak, B. Rees Smith, et al. 2006. Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies. J. Clin. Endocrinol. Metab. 91: 1637-1645.
7. Irvine, W. J., A. G. Stewart, and L. Scarth. 1967. A clinical and immunological study of adrenocortical insufficiency (Addison's disease). Clin. Exp. Immunol. 2: 31-70.
8. Betterle, C., C. D. Pra, B. Pedini, R. Zanchetta, M. P. Albergoni, S. Chen, J. Furmaniak, and B. R. Smith. 2004. Assessment of adrenocortical function and autoantibodies in a baby born to a mother with autoimmune polyglandular syndrome type 2. J. Endocrinol. Invest. 27: 618-621.
9. Bratland, E., B. Skinningsrud, D. E. Undlien, E. Mozes, and E. S. Husebye. 2009. T cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiency. J. Clin. Endocrinol. Metab. 94: 5117-5124.
10. Freeman, M., and A. P. Weetman. 1992. T and B cell reactivity to adrenal antigens in autoimmune Addison's disease. Clin. Exp. Immunol. 88: 275-279.
11. Rottembourg, D., C. Deal, M. Lambert, R. Mallone, J. C. Carel, A. Lacroix, S. Caillat-Zucman, and F. le Deist. 2010. 21-Hydroxylase epitopes are targeted by CD8 T cells in autoimmune Addison's disease. J. Autoimmun. 35: 309-315.
12. Romero, P., P. R. Dunbar, D. Valmori, M. Pittet, G. S. Ogg, D. Rimoldi, J. L. Chen, D. Liénard, J. C. Cerottini, and V. Cerundolo. 1998. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J. Exp. Med. 188: 1641-1650.
13. Hermans, I. F., J. D. Silk, J. Yang, M. J. Palmowski, U. Gileadi, C. McCarthy, M. Salio, F. Ronchese, and V. Cerundolo. 2004. The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo. J. Immunol. Methods 285: 25-40.
14. Rainey, W. E., I. M. Bird, and J. I. Mason. 1994. The NCI-H295 cell line: a pluripotent model for human adrenocortical studies. Mol. Cell. Endocrinol. 100: 45-50.
15. Kent, S. C., Y. Chen, L. Bregoli, S. M. Clemmings, N. S. Kenyon, C. Ricordi, B. J. Hering, and D. A. Hafler. 2005. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 435: 224-228.
16. Oshima, M., P. R. Deitiker, R. G. Smith, D. Mosier, and M. Z. Atassi. 2012. T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients. Autoimmunity 45: 153-160.
17. Winqvist, O., J. Gustafsson, F. Rorsman, F. A. Karlsson, and O. Kämpe. 1993. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J. Clin. Invest. 92: 2377-2385.
18. Zhou, Z., V. R. Agarwal, N. Dixit, P. White, and P. W. Speiser. 1997. Steroid 21- hydroxylase expression and activity in human lymphocytes. Mol. Cell. Endocrinol. 127: 11-18.
19. Wood, M. A., and G. D. Hammer. 2011. Adrenocortical stem and progenitor cells: unifying model of two proposed origins. Mol. Cell. Endocrinol. 336: 206-212.
20. Gan, E. H., K. MacArthur, A. L. Mitchell, B. A. Hughes, P. Perros, S. G. Ball, R. A. James, R. Quinton, S. Chen, J. Furmaniak, et al. 2014. Residual adrenal function in autoimmune Addison's disease: improvement after tetracosactide (ACTH1-24) treatment. J. Clin. Endocrinol. Metab. 99: 111-118.
21. Harkiolaki, M., S. L. Holmes, P. Svendsen, J. W. Gregersen, L. T. Jensen, R. McMahon, M. A. Friese, G. van Boxel, R. Etzensperger, J. S. Tzartos, et al. 2009. T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. Immunity 30: 348-357.
22. Skowera, A., R. J. Ellis, R. Varela-Calviño, S. Arif, G. C. Huang, C. Van-Krinks, A. Zaremba, C. Rackham, J. S. Allen, T. I. Tree, et al. 2008. CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucoseregulated preproinsulin epitope. J. Clin. Invest. 118: 3390-3402.
23. Li, C. K., H. Wu, H. Yan, S. Ma, L. Wang, M. Zhang, X. Tang, N. J. Temperton, R. A. Weiss, J. M. Brenchley, et al. 2008. T cell responses to whole SARS coronavirus in humans. J. Immunol. 181: 5490-5500.
24. Davis, I. D., W. Chen, H. Jackson, P. Parente, M. Shackleton, W. Hopkins, Q. Chen, N. Dimopoulos, T. Luke, R. Murphy, et al. 2004. Recombinant NYESO- 1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans. Proc. Natl. Acad. Sci. USA 101: 10697-10702.
25. Wilkinson, T. M., C. K. Li, C. S. Chui, A. K. Huang, M. Perkins, J. C. Liebner, R. Lambkin-Williams, A. Gilbert, J. Oxford, B. Nicholas, et al. 2012. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat. Med. 18: 274-280.
26. Mitchell, A. L., and S. H. Pearce. 2012. Autoimmune Addison disease: pathophysiology and genetic complexity. Nat. Rev. Endocrinol. 8: 306-316.